tiprankstipranks
CervoMed price target lowered to $4 from $45 at Roth MKM
PremiumThe FlyCervoMed price target lowered to $4 from $45 at Roth MKM
3M ago
CervoMed price target lowered to $12 from $65 at Canaccord
Premium
The Fly
CervoMed price target lowered to $12 from $65 at Canaccord
3M ago
CervoMed downgraded to Underweight from Overweight at Morgan Stanley
Premium
The Fly
CervoMed downgraded to Underweight from Overweight at Morgan Stanley
3M ago
CervoMed Faces Setback in Phase 2b Trial
PremiumCompany AnnouncementsCervoMed Faces Setback in Phase 2b Trial
3M ago
CervoMed announces RewinD-LB Phase 2b did not meet primary endpoint
Premium
The Fly
CervoMed announces RewinD-LB Phase 2b did not meet primary endpoint
3M ago
CervoMed initiated with Buy into ‘binary readout’ at Roth MKM
Premium
The Fly
CervoMed initiated with Buy into ‘binary readout’ at Roth MKM
3M ago
CervoMed initiated with a Buy at D. Boral Capital
PremiumThe FlyCervoMed initiated with a Buy at D. Boral Capital
4M ago
CervoMed appoints Ordonez, Rosch as SVPs
Premium
The Fly
CervoMed appoints Ordonez, Rosch as SVPs
4M ago
CervoMed Inc. Reports Increased R&D Expenses Amid Ongoing Trials
Premium
Company Announcements
CervoMed Inc. Reports Increased R&D Expenses Amid Ongoing Trials
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100